The EYERISING Study

The purpose of this clinical trial is to see if and how well Repeated Low-Level Red Light (RLRL) therapy works to control myopia over 12 months. The main question it aims to answer is: * Can RLRL therapy help slow down the worsening of myopia? Participants will use a red-light therapy investigational device at home, 5 days a week for 12 months.

Inclusion Criteria: * Age ≥ 6 and ≤ 12 (at screening) * Myopia: Cycloplegic SER -1.0 to -7.0 D * Astigmatism: \< 1.5 D * Anisometropia: \< 1.5 D * Informed parental consent * Consistent access to wireless internet Exclusion Criteria: * A subject who is born female and who is currently menstruating or has begun menstruation (menarche). * Ophthalmic diseases, conditions, or syndromes other than refractive errors * Previous use of treatment for myopia control (e.g., defocusing lenses or contact lenses, orthokeratology, atropine, and pirenzepine) * Any previous ocular surgery * Systemic diseases (e.g., endocrine, cardiac diseases) and developmental anomalies * Inability to attend regular follow up visits * Participants with any symptom, disease, or other condition that, in the opinion of the investigators, may affect the effectiveness of the investigational treatment and/or the ability of the participant to complete study activities